Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a randomized open label study in de novo liver transplant recipients that aims to compare the risk of tacrolimus induced tremors with once daily extended-release formulation, Envarsus, versus the twice daily immediate-release formulation. Both formulations of tacrolimus are currently approved for the prevention of rejection in liver transplant patients.
Epistemonikos ID: cd38c25c89542e15fcecc7b0da831726ce3e2ecf
First added on: May 09, 2024